PH30828A - Sunscreen agents. - Google Patents

Sunscreen agents.

Info

Publication number
PH30828A
PH30828A PH45755A PH45755A PH30828A PH 30828 A PH30828 A PH 30828A PH 45755 A PH45755 A PH 45755A PH 45755 A PH45755 A PH 45755A PH 30828 A PH30828 A PH 30828A
Authority
PH
Philippines
Prior art keywords
layered double
metal
sunscreen agents
nmnn
zh2o
Prior art date
Application number
PH45755A
Other languages
English (en)
Inventor
Carr Stuart
Kevin R Franklin
Charles C Nunin
Jeffrey J Pasternak
Ian R Scott
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of PH30828A publication Critical patent/PH30828A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0254—Platelets; Flakes
    • A61K8/0258—Layered structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PH45755A 1992-02-21 1993-02-22 Sunscreen agents. PH30828A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203806A GB9203806D0 (en) 1992-02-21 1992-02-21 Sunscreen agents

Publications (1)

Publication Number Publication Date
PH30828A true PH30828A (en) 1997-10-17

Family

ID=10710858

Family Applications (1)

Application Number Title Priority Date Filing Date
PH45755A PH30828A (en) 1992-02-21 1993-02-22 Sunscreen agents.

Country Status (13)

Country Link
EP (1) EP0557089B1 (ja)
JP (1) JP3600254B2 (ja)
KR (1) KR930017566A (ja)
AT (1) ATE138560T1 (ja)
AU (1) AU663558B2 (ja)
BR (1) BR9300640A (ja)
CA (1) CA2089950C (ja)
DE (1) DE69302839T2 (ja)
ES (1) ES2089720T3 (ja)
GB (1) GB9203806D0 (ja)
PH (1) PH30828A (ja)
TW (1) TW301609B (ja)
ZA (1) ZA931194B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316901D0 (en) * 1993-08-13 1993-09-29 Unilever Plc Sunscreen agents
DE4443243C2 (de) * 1994-11-24 1998-02-19 Lancaster Group Gmbh Sonnenschutzzubereitung mit erhöhtem Lichtschutzfaktor
GB9424445D0 (en) * 1994-12-02 1995-01-18 Unilever Plc Cosmetic composition
US6153176A (en) * 1995-01-20 2000-11-28 The Procter & Gamble Company Low pH sunscreen compositions
DE19835691A1 (de) † 1998-08-07 2000-02-10 Merck Patent Gmbh pH-stabilisiertes ZnO in Sonnenschutzformulierungen
KR100359716B1 (ko) * 1998-09-11 2003-04-21 (주)나노하이브리드 유전자의보관및전달이가능한생-무기하이브리드복합체및그의제조방법
KR100439299B1 (ko) * 2001-07-28 2004-07-07 (주)나노하이브리드 개선된 특성을 갖는 화장품 원료 물질 및 그 제조 방법
DE102006024289A1 (de) * 2006-05-24 2007-11-29 Merck Patent Gmbh Partikel
US20110244008A1 (en) * 2008-12-12 2011-10-06 Xing Dong Wang Cosmetic composition
PL3311666T3 (pl) 2010-08-18 2021-11-08 Biosplice Therapeutics, Inc. Diketony i hydroksyketony jako aktywatory szlaku sygnałowego kateniny
WO2012081135A1 (en) * 2010-12-17 2012-06-21 L'oreal Cosmetic composition
WO2012081133A1 (en) * 2010-12-17 2012-06-21 L'oreal Make-up cosmetic composition comprising a layered double hydroxide
SI2968249T1 (sl) 2013-02-22 2019-04-30 Samumed, Llc Gama-diketoni kot aktivatorji signalne poti Wnt/beta-katenin
EP3134487A1 (en) * 2014-04-22 2017-03-01 Wintershall Holding GmbH Process for recovery of oil
EA201692123A1 (ru) * 2014-04-22 2017-04-28 Винтерсхол Хольдинг Гмбх Стабилизированная твердыми веществами эмульсия
EP3206686B1 (en) 2014-08-20 2019-10-09 Samumed, LLC Gamma-diketones for treatment and prevention of aging skin and wrinkles
JP6589724B2 (ja) * 2016-03-31 2019-10-16 堺化学工業株式会社 複合体の製造方法
JP6831569B2 (ja) * 2017-06-13 2021-02-17 公立大学法人大阪 紫外・赤外線吸収剤
WO2020053920A1 (ja) * 2018-09-10 2020-03-19 共栄社化学株式会社 イオン伝導性材料、電池用機能層及びその製造方法
JP7421797B2 (ja) * 2020-03-30 2024-01-25 株式会社海水化学研究所 紫外線吸収剤
CN115232485B (zh) * 2022-07-13 2023-11-07 塔里木大学 一种蛭石紫外阻隔材料及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087555A (en) * 1975-09-08 1978-05-02 Helena Rubinstein, Inc. Skin cream containing milk protein
US4664843A (en) * 1985-07-05 1987-05-12 The Dow Chemical Company Mixed metal layered hydroxide-clay adducts as thickeners for water and other hydrophylic fluids
DE3838532A1 (de) * 1988-11-14 1990-05-17 Henkel Kgaa Faellmittel oder flockungsmittel zur abwasserbehandlung und verfahren unter verwendung dieser mittel
GB8925473D0 (en) * 1989-11-10 1989-12-28 Unilever Plc Sunscreen compositions
DE4018628A1 (de) * 1990-06-11 1991-12-12 Henkel Kgaa Koagulationsmittel auf der basis von doppelschichthydroxid-verbindungen
DE4020272A1 (de) * 1990-06-26 1992-01-02 Henkel Kgaa Pigmente auf basis von doppelschicht-hydroxiden, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
CA2089950C (en) 1999-05-25
GB9203806D0 (en) 1992-04-08
JP3600254B2 (ja) 2004-12-15
DE69302839D1 (de) 1996-07-04
DE69302839T2 (de) 1996-10-02
EP0557089A1 (en) 1993-08-25
KR930017566A (ko) 1993-09-20
CA2089950A1 (en) 1993-08-22
ATE138560T1 (de) 1996-06-15
JPH069358A (ja) 1994-01-18
EP0557089B1 (en) 1996-05-29
AU663558B2 (en) 1995-10-12
TW301609B (ja) 1997-04-01
BR9300640A (pt) 1993-08-24
AU3318493A (en) 1993-08-26
ES2089720T3 (es) 1996-10-01
ZA931194B (en) 1994-08-19

Similar Documents

Publication Publication Date Title
AU663558B2 (en) Sunscreen agents
CA2166467A1 (en) Sunscreen agents
CA2208078A1 (en) Formulations and methods for reducing skin irritation
PL320935A1 (en) Compositions for and methods of reducing skin irritation
IN172457B (ja)
WO1996012498A3 (en) Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
EP0697872A4 (en) TRICYCLOPOLYAZAMACROCYCLOPHOSPHONIC ACIDS, COMPLEXES AND DERIVATIVES THEREOF, FOR USE AS CONTRAST AGENTS
CA2487803A1 (en) Multi-step cosmetic benefit foundation kit and associated methods
MX210154B (ja)
AU2852395A (en) Method for forming aggregation body by thermocompression
CA2111559A1 (en) Finely divided, highly pure neutral zinc oxide powder, a process for its preparation and its use
CA2061679A1 (en) Cationic compositions for skin
SG54597A1 (en) Process for the protection of elastane fibres
GB9323808D0 (en) Composition containing zinc for the treatment of skin disorders
CA2116829A1 (en) Use of a pregnane derivative
EP1038524A4 (en) L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR IMPROVEMENT AND TREATMENT OF ANEMIA IN PEOPLE
AU653331B2 (en) The use of zinc calcium hydroxide, lecithin and PAO as an adjuvant for antigen solutions, and antigen solutions treated with an adjuvant of this type
CA2132528A1 (en) Agent for use as an anti-irritant
TH13045A (th) สารปกป้องแสงแดด
TH13045EX (th) สารปกป้องแสงแดด
TH20796B (th) สารปกป้องแสงแดด
MX9704732A (es) Formulaciones para reducir irritacion de la piel y su uso.
AU2220292A (en) Functional fluid with borated epoxides, carboxylic solubilizers, zinc salts, calcium complexes and sulfurized compositions
TH16102A (th) สารป้องกันแสงแดด
AU6739690A (en) Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans